Lymphocyte function following radium-223 therapy in patients with metastasized, castration-resistant prostate cancer.
Vahé BarsegianStefan P MüllerDaniel MöckelPeter A HornAndreas BockischMonika LindemannPublished in: European journal of nuclear medicine and molecular imaging (2016)
The results argue against an impairment of lymphocyte function after 223Ra therapy. Thus, immune responses against pathogens should remain unaffected.